BIOMAT Database Logo BIOMAT Database Logo

Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors. 2004

J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz

UI MeSH Term Description Entries
D008297 Male Males
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes

Related Publications

J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.
June 2001, Antiviral therapy,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV.
January 2005, HIV clinical trials,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
[The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
August 2006, Nederlands tijdschrift voor geneeskunde,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects.
March 2004, AIDS (London, England),
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
December 2010, The Cochrane database of systematic reviews,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors.
September 2003, Journal of acquired immune deficiency syndromes (1999),
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.
January 2012, Expert opinion on pharmacotherapy,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
December 2016, The Cochrane database of systematic reviews,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
HIV nucleoside reverse transcriptase inhibitors.
October 2022, European journal of medicinal chemistry,
J A Arranz-Caso, and M Gorgolas, and V Estrada, and J D García-Diaz
Non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine inhibit cytochrome C oxidase in mouse brain regions.
June 2011, Neurochemical research,
Copied contents to your clipboard!